00946nam2 2200325 450 99000305545020331620080124132219.0000305545USA01000305545(ALEPH)000305545USA0100030554520080124d--------km-y0itay50------bafreFR||||||||001yySylloge nummorum graecorum. FranceBibliothèque nationale, Cabinet des medailles[poi] Département des monnaies, médailles et antiquesParisBibliothèque nationalev.30 cm20012001001-------2001ITsalbcISBD990003055450203316I NSDBCI NSBKDBCDBC9020080124USA011321DBC9020080124USA011322Sylloge nummorum Graecorum. France727794UNISA02708nam 2200481 450 991079062750332120230802010704.01-74224-597-8(CKB)2550000001134046(EBL)1600442(MiAaPQ)EBC6215957(MiAaPQ)EBC1072995(MiAaPQ)EBC1600442(Au-PeEL)EBL1072995(OCoLC)818851418(EXLCZ)99255000000113404620200922d2012 uy 0engur|n|---|||||txtrdacontentcrdamediacrrdacarrierAn icon in crisis the reinvention of CSIRO /Ron Sandland and Graham ThompsonSydney, Australia :University of New South Wales Press,2012.1 online resource (380 p.)Description based upon print version of record.1-74223-339-2 1-306-02504-4 Contents; Acknowledgments; Acronyms; Foreword; Preface; PART I: A glorious past: but what of the future?; 1. CSIRO January 2001; 2. Big hairy audacious goals; 3. A new way of doing science; 4. Building up steam; 5. Emerging challenges; 6. Finding the money to do it; 7. The challenges of governance in a creative organisation; PART II: Dealing with the issues; 8. 2001: A cultural odyssey; 9. Roles, authority, responsibility: Who does what to whom?; 10. Surviving in Horizon 2: Making ends meet; 11. Help wanted: But where to find it?; 12. Getting the message across; Part III: Facing the Future13. Transition to a truly national initiative14. Full steam ahead; 15. Lessons learned; Conclusion; Appendices; Glossary; Notes; References; IndexIn 2001, CSIRO's future looked shaky. The Australian government had announced a big increase in public funding for science, but had pointedly left the iconic national research agency out when it came to distributing the cash. Facing the threat of funding cuts and loss of reputation, CSIRO set about reinventing itself through what became known as its National Flagship Initiative. This book is the story of that program, told by Ron Sandland who led the initiative and Graham Thompson who designed its systems and processes. To achieve the changes that were necessary for its survival, CSIRO had to Organizational changeAustraliaOrganizational change306.20994Sandland Ron1492078Thompson GrahamMiAaPQMiAaPQMiAaPQBOOK9910790627503321An icon in crisis3714336UNINA03889nam 22005775 450 991061638990332120260209100517.0981-19-2677-810.1007/978-981-19-2677-8(MiAaPQ)EBC7109696(Au-PeEL)EBL7109696(CKB)25115885400041(PPN)265861039(DE-He213)978-981-19-2677-8(OCoLC)1347697124(EXLCZ)992511588540004120221012d2022 u| 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierAtlas of Nuclear Medicine in Musculoskeletal System Case-Oriented Approach /edited by Seoung-Oh Yang, So Won Oh, Yun Young Choi, Jin-Sook Ryu1st ed. 2022.Singapore :Springer Nature Singapore :Imprint: Springer,2022.1 online resource (266 pages)Medicine SeriesPrint version: Yang, Seoung-Oh Atlas of Nuclear Medicine in Musculoskeletal System Singapore : Springer,c2022 9789811926761 Includes bibliographical references and index.Part I Inflammatory and Infectious Disorders -- 1 Musculoskeletal infections -- 2 Septic Arthritis -- 3 Inflammatory arthritis -- 4 Non-inflammatory arthritis: Osteoarthritis -- 5 Hypertrophic Osteoarthropathy -- Part II Traumatic and Circulatory Disorders -- 6 Fracture, non-union and bone graft -- 7 Stress Fractures and Sports Injury -- 8 Osteonecrosis -- 9 Complex regional pain syndrome -- Part III Spine and Joint Disorders -- 10 Spine -- 11 Hip -- 12 Knee prostheses -- 13 Ankle and shoulder -- Part IV Metabolic and Endocrine Osseous Disorders -- 14 Metabolic Bone Disease -- 15 Osteoporosis -- 16 Fibrous Dysplasia -- Part V Musculoskeletal Neoplastic Disorders -- 17 Primary Bone and Soft Tissue Tumors -- 18 Metastatic musculoskeletal tumors -- 19 Marrow Replacement Disorders -- Part VI Miscellaneous Features in Musculoskeletal Nuclear Imaging -- 20 Soft Tissue Uptake of Bone Scan Agents -- 21 Musculoskeletal Nuclear Imaging Pitfalls.Nuclear medicine imaging in the musculoskeletal system with its ability to assess disease activities has contributed to accurate diagnosis and improved medical and surgical treatment. Several nuclear medicine textbooks and case studies in forms of atlases have been published so far, but there seems to be no in-depth nuclear medicine imaging atlas focused on diseases of the musculoskeletal system. Therefore, the authors have written about common cases as well as rare musculoskeletal disorders for which various imaging techniques of nuclear medicine (bone scan, SPECT, SPECT/CT, PET/CT, PET/MR, etc.) are useful based on their clinical experience in many different hospitals. This book intends to share the experiences of the authors with nuclear medicine and radiology residents and board specialists, and to help other clinicians who manage musculoskeletal disorders, such as orthopedic and rheumatology, through various cases of musculoskeletal disorders by providing algorithmic imaging utilization to support their patient care. .Medicine SeriesNuclear medicineNuclear MedicineMalalties de l'aparell locomotorthubMedicina nuclearthubAtles (Científic)thubLlibres electrònicsthubNuclear medicine.Nuclear Medicine.Malalties de l'aparell locomotorMedicina nuclear616.707548Yang Seoung-OhMiAaPQMiAaPQMiAaPQBOOK9910616389903321Atlas of Nuclear Medicine in Musculoskeletal System2950634UNINA